Company News

Partnership introduces unique patient recruitment and engagement platform to Canada TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and uMed, the UK-based provider of a leading automated patient-recruitment platform, are pleased to announce a partnership…

NEW YORK, August 29, 2022 — A first-of-its-kind patient cohort platform will soon be available to UK and US researchers struggling to recruit patients with interstitial lung disease (ILD), such as pulmonary fibrosis and progressing fibrosis resulting from COVID-19. UK-based company uMed announced the launch of the Access-ILD/PF Cohort at the sixth annual Idiopathic Pulmonary…

An article published in the Journal of Clinical Studies describing the benefits of uMed in clinical trial recruitment

An automated patient recruitment platform (ARP) could help researchers recruit patients significantly faster into clinical studies across diverse disease areas, helping researchers identify new treatments for diseases more quickly, tech platform creator uMed says.

Pharma Business International features uMed CEO Matt Wilson. He discusses uMed’s growth as a health technology company and the importance of building trust with all stakeholders.

uMed raises $4.8m in venture capital funding to help healthcare providers participate in more clinical studies.

Growth Business highlights 3 tech start-ups actively fighting the Covid-19 pandemic that are open for investment to fund further research and development.

We are excited to share uMed are in the Top 20 of the BusinessCloud’s 100 HealthTech Pioneers ranking for 2020! Well done to the uMed team for all their continued hard work!

uMed’s Ian Wootton joined the debate on Integrated Healthcare, hosted by the UKs Department for International Trade at Arab Health.